Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mission Cancer + Blood is an Iowa-based community oncology and hematology practice network that provides outpatient cancer and blood-disorder care through more than 20 clinics across the state. Its services include medical oncology, hematology, chemotherapy infusion, on-site laboratory services, genetic counseling, multidisciplinary tumor boards, and access to clinical trials. Founded in 1981, the organization built a large rural and community-focused footprint in Iowa and became part of University of Iowa Health Care following an asset purchase completed on December 31, 2024. Mission now operates as a care-delivery brand within UI Health Care’s statewide cancer network rather than as an independent drug-development biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mission Cancer + Blood.